Esic, Edna H.
HRN: 24-19-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/04/2023
12/12/2023
IV
500mg
TID
Gastroenteritis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes